BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bossert JM, Kiyatkin EA, Korah H, Hoots JK, Afzal A, Perekopskiy D, Thomas S, Fredriksson I, Blough BE, Negus SS, Epstein DH, Shaham Y. In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia. Biol Psychiatry 2020;88:935-44. [PMID: 32305216 DOI: 10.1016/j.biopsych.2020.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Ventriglia E, Rizzo A, Gomez JL, Friedman J, Lam S, Solís O, Rais R, Bonaventura J, Michaelides M. Essential role of P-glycoprotein in the mechanism of action of oliceridine. Neuropsychopharmacol 2022. [DOI: 10.1038/s41386-022-01507-x] [Reference Citation Analysis]
2 Bossert JM, Mejias-aponte CA, Saunders T, Altidor L, Emery M, Fredriksson I, Batista A, Claypool SM, Caldwell KE, Reiner DJ, Chow JJ, Foltz M, Kumar V, Seasholtz A, Hughes E, Filipiak W, Harvey BK, Richie CT, Vautier F, Gomez JL, Michaelides M, Kieffer BL, Watson SJ, Akil H, Shaham Y. Effect of selective lesions of nucleus accumbens μ-opioid receptor-expressing cells on heroin self-administration in male and female rats: a study with novelOprm1-Creknock-in rats.. [DOI: 10.1101/2022.11.02.514895] [Reference Citation Analysis]
3 Valyear MD, LeCocq MR, Brown A, Villaruel FR, Segal D, Chaudhri N. Learning processes in relapse to alcohol use: lessons from animal models. Psychopharmacology (Berl) 2022. [PMID: 36264342 DOI: 10.1007/s00213-022-06254-x] [Reference Citation Analysis]
4 Kallupi M, de Guglielmo G, Conlisk D, Brennan M, Tieu L, Sedighim S, Boomhower B, Smith LC, Shankar K, Carrette LL, Simpson S, Avelar A, Maturin L, Martinez A, Qiao R, Dirik S, Crook C, Bonnet-zahedi S, Iyer MR, Blucher CE, Fannon MJ, Woods LCS, Palmer AA, George O. Identification of individual differences in response to methadone, buprenorphine, and naltrexone in animal models of opioid use disorder.. [DOI: 10.1101/2022.07.23.501217] [Reference Citation Analysis]
5 Chow JJ, Beacher NJ, Chabot JM, Oke M, Venniro M, Lin DT, Shaham Y. Characterization of operant social interaction in rats: effects of access duration, effort, peer familiarity, housing conditions, and choice between social interaction vs. food or remifentanil. Psychopharmacology (Berl) 2022. [PMID: 35230469 DOI: 10.1007/s00213-022-06064-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Nicolas C, Zlebnik NE, Farokhnia M, Leggio L, Ikemoto S, Shaham Y. Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review. Pharmacol Rev 2022;74:119-40. [PMID: 34987089 DOI: 10.1124/pharmrev.121.000367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
7 Banks ML. Environmental influence on the preclinical evaluation of substance use disorder therapeutics. Behavioral Pharmacology of Drug Abuse: Current Status 2022. [DOI: 10.1016/bs.apha.2021.10.004] [Reference Citation Analysis]
8 Acevedo-canabal A, Pantouli F, Ravichandran A, Rullo L, Bohn LM. Pharmacological Diversity in Opioid Analgesics: Lessons From Clinically Useful Drugs. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00188-2] [Reference Citation Analysis]
9 Azzam AAH, Lambert DG. Preclinical Discovery and Development of oliceridine (Olinvyk®) for the Treatment of Post-Operative Pain. Expert Opin Drug Discov 2021. [PMID: 34817313 DOI: 10.1080/17460441.2022.2008903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bossert JM, Townsend EA, Altidor LK, Fredriksson I, Shekara A, Husbands S, Sulima A, Rice KC, Banks ML, Shaham Y. Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance. Br J Pharmacol 2021. [PMID: 34505281 DOI: 10.1111/bph.15679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Fredriksson I, Venniro M, Reiner DJ, Chow JJ, Bossert JM, Shaham Y. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review. Pharmacol Rev 2021;73:1050-83. [PMID: 34257149 DOI: 10.1124/pharmrev.120.000191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
12 George BE, Barth SH, Kuiper LB, Holleran KM, Lacy RT, Raab-Graham KF, Jones SR. Enhanced heroin self-administration and distinct dopamine adaptations in female rats. Neuropsychopharmacology 2021;46:1724-33. [PMID: 34040157 DOI: 10.1038/s41386-021-01035-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
13 Anderson EM, Engelhardt A, Demis S, Porath E, Hearing MC. Remifentanil self-administration in mice promotes sex-specific prefrontal cortex dysfunction underlying deficits in cognitive flexibility. Neuropsychopharmacology 2021;46:1734-45. [PMID: 34012018 DOI: 10.1038/s41386-021-01028-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
14 Pantazis CB, Gonzalez LA, Tunstall BJ, Carmack SA, Koob GF, Vendruscolo LF. Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction. Sci Adv 2021;7:eabf0364. [PMID: 33827822 DOI: 10.1126/sciadv.abf0364] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
15 Nicolas C, Zlebnik NE, Farokhnia M, Leggio L, Ikemoto S, Shaham Y. Sex differences in opioid and psychostimulant craving and relapse: a critical review.. [DOI: 10.1101/2021.03.30.21254644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Townsend EA, Schwienteck KL, Robinson HL, Lawson ST, Banks ML. A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders. J Neurosci Methods 2021;354:109110. [PMID: 33705855 DOI: 10.1016/j.jneumeth.2021.109110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
17 Fakira AK, Devi LA, Kennedy PJ. Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention. Biol Psychiatry 2020;88:896-7. [PMID: 33213702 DOI: 10.1016/j.biopsych.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Townsend EA, Kim RK, Robinson HL, Marsh SA, Banks ML, Hamilton PJ. Opioid withdrawal produces sex-specific effects on fentanyl-vs.-food choice and mesolimbic transcription.. [DOI: 10.1101/2021.01.14.426662] [Reference Citation Analysis]